Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2016; 62(6): 50-59


L.M. Shapoval, B.S. Kop’yak, O.V. Dmytrenko, V.O. Mayskiy, O.P. Mankivska, V.F. Sagach

    OO.Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv


The study was conducted on rats with unilateral damage to dopaminergic (DA) neurons in substantia nigra of the midbrain (experimental hemiparkinsonism). Degeneration of dopaminergic (DA) neurons was accompanied by hyperactivity of those neurons that remained intact and responded to apomorphine (Apo) test by rotational movements. Depending on the number of rotations, three groups of animals were defined. In the medulla oblongata of rats with unilateral damage to dopaminergic (DA) neurons, a significant increase in the activity of inducible NO-synthase (iNOS) was observed, while the activity of constitutive NO-synthase (cNOS) tended to decrease compared with that in control rats. An activation of neuronal NO-synthase (nNOS) in those rats by injections of L-arginine in the medullary nuclei was accompanied by weakening of the hemodynamic effects compared to those in control rats. An exposure of animals to continuous light for three weeks was accompanied by increasing the number of damaged DA-ergic neurons in substantia nigra. At that, a significant decrease in cNOS activity in the medulla oblongata was observed, leading to the inhibition of de novo synthesis of nitric oxide (NO). The reduction of NO synthesis in the medulla oblongata neurons of rats with experimental hemiparkinsonism following their exposure to continuous light was also evidenced by the reduction of the amount of nitrite (NO2-) anion.

Keywords: nitric oxide; medulla oblongata; substantia nigra; exposure to light.


  1. Magerkurt C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Autonom Res. 2005;15(2):76- 82. CrossRef PubMed
  3. Talanov SA, Kotsuruba AV, Chorna SV, Rudyk OV, Sagach VF. Increased sensitivity of mitochondrial permeability transition causes myocardial dysfunction in rats with chronic deficiency of nigrostriatal dopamine. In: Adv Biomed Res, Univ Cambridge. 2010;318-22.
  5. Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson's disease. Biochem Biophys Acta. 2009;1792(7):643-50.
  7. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR. Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem Res. 2008;33(12):2416-26. CrossRef PubMed
  9. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett. 1991;132:47-50. CrossRef  
  10. Krukoff TI. Central actions of nitric oxide in regulation of autonomic functions. Brain Res. 1999;30:52-65. CrossRef  
  11. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular functions. Cardiovascul Res. 1999; 43:839-649. CrossRef  
  12. Shapoval LN. Nitric oxide and nervous control of cardiovascular function. In: Reseptors, Channels and Messengers. Kostyuk PG, Lukyanetrz EA eds., DUS Kiev. 2005; p.318-37.
  14. Phattanarudee A, Towiwat P, Maher TJ, et al. Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke. Canad J Physiol Pharmacol. 2013;91(7):510-20. CrossRef PubMed
  16. Zanzinger J, Seller H. Species differences in the distribution of nitric oxide synthase in brain stem regions that regulate sympathetic activity. Brain Res. 1997;764:265-68. CrossRef  
  17. Lin LH, Taktakishvili O, TALMAN WT. Identification and localization of cell types that express endothelial and neuronal nitric oxide synthase in the rat nucleus tractus solitarii. Brain Res. 2007; 1171:42-51. CrossRef PubMed PubMedCentral
  19. Aydogan SM, Yerer AB, Goktas Melatonin and nitric oxide J.Endocrinol Invest. 2006;29(3):281-87. CrossRef PubMed
  21. Reiter RJ. Melatonin: cell biology of its synthesis and of its physiological interactions. Endocrinol Rev. 1991; 12:151-80. CrossRef PubMed
  23. Dorminguez-Rodriguez A, Abreu-Gonzalez P, Sanchez JJ. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res. 2010; 49:14-22.
  25. Pechanova O., Paulis L., Simko F. Peripheral and central effects OF melatonin on blood pressure regulation. Int J Mol Sci. 2014;15:17920-937. CrossRef PubMed PubMedCentral
  27. Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res. 2007;56:671-84.
  29. Vazan R, Beder I, Styk J. Melatonin and the heart. Cesk Fysiol. 2004;53:29-33.
  31. Doolen S, Krause DN, Dubocovich ML, et al. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol. 1998;345:67-69. CrossRef  
  32. Dobsak P, Siegelova I, Eicher JC et al. Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis is isolated working rat heart. Pathophysiology. 2003;9:179-87. CrossRef  
  33. Sagach VF, Rudyk OV, Vavilova GL, Kotsiuruba AV, Tkachenko JuP. Melatonin recovers ischemic tolerance and decreases the sensitivity of mitochondrial permeability transition pore opening in the heart of aging rats. Fiziol Zh. 2006;52(3):3-14 [Ukrainian].
  35. Ungerstedt U. 6-hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol. 1968;5:107-10. CrossRef  
  36. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Acad Pres New York, 1982
  38. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of nigrostrial dopamine system. Acta Physiol Scand. 1971;82:69-93. CrossRef  
  39. Agid Y, Javoy F, Glowinski G. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Boil. 1973;245:150-51. CrossRef  
  40. Salter M, Knowles RG, Moncada S. Widespread tissue distribution, species and changes in activity of Ca2+- dependent and Ca2+-independent nitric oxide syntases. FEBS Lett. 1991;291:145-49. CrossRef  
  41. Chin SY, Pandey KN, Shi SJ, et al. Increased activity and expression of Ca2+-dependent NOS in renal cortex of ANG II-infused hypertensive rats. Amer J Physiol. 1999;277:797-804.
  43. Durante W, Johnson F.K., Johnson A.J. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol. Physiol. 2007;34(9):906-11.
  45. Boyde J.R, Rahmotullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetil monoxime. Anal Biochem. 1980;107:424-31. CrossRef  
  46. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Market SP. Light suppresses melatonin secretion in humans. Science, 1980, 210 (4475), 1267-69

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.